Skip to main content

Understand. Power. Act.

The Library

New

One story, all the way down.

Feds unlikely to change abortion pill policy before next year

The U.S. Food and Drug Administration said late Wednesday that it expects to complete its long-awaited safety review of abortion pills by mid-December and issue a report evaluating the results by March 2027. The agency disclosed the information in a court-mandated status report it submitted in the federal lawsuit Louisiana v. FDA. The timeline aligns […]

Sources (1)· Oct 8, 2:38 PM

abortion pill policy review Health

Every telling

their own versions

Stateline· Oct 8, 2:38 PMFeds unlikely to change abortion pill policy before next year

More like this

similar stories in the archive

FDA says it will complete safety review of abortion pill in MarchA federal judge in Louisiana ordered the agency to provide an update on its safety study as part of a lawsuit seeking to overturn a provision allowing mifepristone to be delivered by mail.

NBC News2d agoSources (2)Whole story →

Health abortion pill safety review

FDA says its review of abortion pill will continue into next yearThe Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year

ABC News2d agoWhole story →

Health abortion pill review

Trump Finally Gives Update on Deadly Drug—Why Its Opponents Are Not HappyThe Food and Drug Administration plans to complete its long-awaited review of abortion drugs in mid-December, but the public won’t see the results until March, according to a Wednesday filing from the Justice Department. The 5th Circuit Court ordered the FDA to provide an update on its abortion pill safety review by Oct. 7, after...

The Daily Signal2d agoWhole story →

Health abortion pill review update

FDA: Mifepristone review won't be done until MarchThe Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion activists, who have been losing patience with the...

The Hill2d agoWhole story →

Health mifepristone fda review

FDA Says It Won’t Act On Abortion Drugs Till March, 2 Years After Pledging To Review Safety ConcernsThe final review is expected more than two years after RFK Jr. and the former FDA commissioner pledged to ‘study the safety’ of abortion pills.

The Federalist2d agoWhole story →

Health fda abortion pill review delay

Senators to question FDA nominee about her views on abortion pill and vaccinesPresident Donald Trump’s pick to run the Food and Drug Administration will face questions from Senate lawmakers considering her nomination.

WDIV ClickOnDetroit16d agoWhole story →

Government Donald Trump Bill Cassidy fda nominee hearing

U.S. appeals court hears Louisiana abortion pill caseAttorney General Liz Murrill asked an appeals court Wednesday to strike down a federal government policy allowing abortion pills to be mailed over state lines, saying the regulation has snarled enforcement of Louisiana’s anti-abortion laws in a case that could shape access to the procedure nationwide.

Baton Rouge Advocate1mo agoWhole story →

Health abortion pill case appeal

Federal judges hear abortion pill caseA panel of federal judges heard arguments Wednesday over whether prescribing rules should be tightened for a key drug used in the most common abortion method in the United States, one of several ongoing efforts to restrict abortion access four years after the U.S. Supreme Court allowed states to decide the issue.

Arkansas Online1mo agoWhole story →

Health abortion pill case hearing

Feds unlikely to change abortion pill policy before next year – KnowGov